TV7-15146-66184
3 vaccinations
1 coded response
9 check-ins
0 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 26-30
- ZIP prefix
- 712 / LA
- Registered
- 2022-01-10
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2020-12-21
Dose 1 — Pfizer-BioNTech
-
2021-01-11
Dose 2 — Pfizer-BioNTech
-
2022-01-07
Dose 3 — Pfizer-BioNTech
-
2022-01-10
Registered in v-safe
-
2022-01-10
Health check-in — days 1–6 daily, dose 3Feeling: Poor · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to work or attend schoolAdult check-in
-
2022-01-11
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Fever · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to work or attend school, Be unable to do your normal daily activitiesAdult check-in
-
2022-01-12
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Headache, Muscle or body aches, Fatigue or tiredness, Diarrhea, Abdominal pain · Be unable to work or attend school, Be unable to do your normal daily activitiesAdult check-in
-
2022-01-13
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Headache, Fatigue or tiredness, Nausea, Diarrhea · Be unable to work or attend school, Be unable to do your normal daily activitiesAdult check-in
-
2022-01-14
Health check-in — day 7, dose 3Feeling: Fair · Headache, Fatigue or tiredness, Nausea, Diarrhea, Abdominal pain · Be unable to work or attend school, Be unable to do your normal daily activitiesAdult check-in
- 2022-01-21
- 2022-01-30
- 2022-02-11
-
2023-01-09
Survey response — 12 months, dose 3MedDRA: Blood thyroid stimulating hormone increased, Contraception, Diarrhoea, Gastrointestinal disorder, Menstruation irregular, Nausea — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitMedDRA releases: 2024-11
-
2023-01-09
Report sent to call center — 12 months, dose 3Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prOutpatient clinic or urgent care clinic visit · 1 call case(s)
- 2023-01-10
- 2023-01-13
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2020-12-21 | Pfizer-BioNTech | No |
| 2 | 2021-01-11 | Pfizer-BioNTech | No |
| 3 | 2022-01-07 | Pfizer-BioNTech | No |
Call center
1 call center case
1 unsuccessful
Free text
None.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Blood thyroid stimulating hormone increased | · | · | ✓ |
| SD | Contraception | · | · | ✓ |
| SD | Diarrhoea | · | · | ✓ |
| SD | Gastrointestinal disorder | · | · | ✓ |
| SD | Menstruation irregular | · | · | ✓ |
| SD | Nausea | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release